AppLovin smashed analyst estimates for the fourth quarter. APP stock surged in extended trading, signaling a breakout.

In response, Super Micro formed a special committee to investigate, which ultimately found no evidence of misconduct. The ...

In a challenging market environment, shares of Eliem Therapeutics, Inc. (CLYM) have reached a 52-week low, dipping to $1.5. According to InvestingPro data, the company maintains a strong financial ...